2015 Q4 Form 10-Q Financial Statement

#000157587215000172 Filed on November 13, 2015

View on sec.gov

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	OCULUS VISIONTECH INC.
	dei	Entity Central Index Key EntityCentralIndexKey	0001107280
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Amendment Flag AmendmentFlag	false
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45572568	shares
	dei	Document Type DocumentType	10-Q
	dei	Trading Symbol TradingSymbol	OVTZ
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2436	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11000	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6839	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5877	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	9275	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	18765	USD
CY2015Q3	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	0	USD
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13572568	shares
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1888	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3825	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	48550	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22270	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	0	USD
CY2015Q3	us-gaap	Assets Assets	9275	USD
CY2014Q4	us-gaap	Assets Assets	18765	USD
CY2015Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	108437	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	66584	USD
CY2015Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	645317	USD
CY2014Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	557226	USD
CY2015Q3	us-gaap	Notes Payable Current NotesPayableCurrent	58399	USD
CY2014Q4	us-gaap	Notes Payable Current NotesPayableCurrent	58399	USD
CY2015Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	520947	USD
CY2014Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	520947	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1333100	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1203156	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	38755638	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	38755638	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-40079463	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39940029	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	-1323825	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-1184391	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9275	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18765	USD
CY2015Q3	us-gaap	Revenues Revenues	0	USD
CY2014Q3	us-gaap	Revenues Revenues	16500	USD
	us-gaap	Revenues Revenues	5500	USD
	us-gaap	Revenues Revenues	49500	USD
CY2015Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1275	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	425	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55050	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	122875	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26523	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19539	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	72928	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	101942	USD
CY2015Q3	us-gaap	Costs And Expenses CostsAndExpenses	75073	USD
CY2014Q3	us-gaap	Costs And Expenses CostsAndExpenses	43084	USD
	us-gaap	Costs And Expenses CostsAndExpenses	128403	USD
	us-gaap	Costs And Expenses CostsAndExpenses	228642	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-75073	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-26584	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-122903	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-179142	USD
CY2015Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-6911	USD
CY2014Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8317	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-21420	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-24777	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	-81984	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	-34901	USD
	us-gaap	Profit Loss ProfitLoss	-139434	USD
	us-gaap	Profit Loss ProfitLoss	-203919	USD
CY2015Q3	ovtz	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable	0	USD
CY2014Q3	ovtz	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable	0	USD
	ovtz	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable	4889	USD
	ovtz	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable	0	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13572568	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13572568	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13572568	shares
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11000	USD
CY2014	us-gaap	Profit Loss ProfitLoss	-260314	USD
CY2013	us-gaap	Profit Loss ProfitLoss	-93608	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4434	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6888	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2454	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	11	USD
CY2015Q3	ovtz	Working Capital Deficit WorkingCapitalDeficit	1323825	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8489	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	962	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-236	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	41853	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	12306	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	88091	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	178454	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	548	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4434	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	548	USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	10228000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	10092000	USD
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	250000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	250000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13572568	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13572568	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13572568	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13572568	shares
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24777	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6911	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8317	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16531	USD
CY2015Q3	ovtz	Working Capital And Current Liabilities WorkingCapitalAndCurrentLiabilities	1330000	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD

Files In Submission

Name	View Source	Status
0001575872-15-000172-index-headers.html	Edgar Link	pending
0001575872-15-000172-index.html	Edgar Link	pending
0001575872-15-000172.txt	Edgar Link	pending
0001575872-15-000172-xbrl.zip	Edgar Link	pending
10q.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
ovtz-20150930.xml	Edgar Link	completed
ovtz-20150930.xsd	Edgar Link	pending
ovtz-20150930_cal.xml	Edgar Link	unprocessable
ovtz-20150930_def.xml	Edgar Link	unprocessable
ovtz-20150930_lab.xml	Edgar Link	unprocessable
ovtz-20150930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending